CannabisLink.ca - Current Affairs 2026

(2026) - Chronological (1501 items)

(All links open in new tab)

Sep 10, 2026	Wisconsin Is Ready To Legalize Marijuana Next Year Under Democratic Or GOP Control, Congressman Says A Democratic congressman who represents Wisconsin says the state is poised to legalize marijuana as soon as next year—especially if his party wins control of the legislature in the November elections, but perhaps even if Republicans maintain a majority under new leadership for the 2027 session. Rep. Mark Pocan (D-WI) told Marijuana Moment that there’s a “really good chance” of legalizing cannabis in Wisconsin in the short term if Democrats can “flip the legislature,” where marijuana reform proposals have stalled under Republican control in recent sessions.
Sep 10, 2026	A Magazine From 1969 Made the Case the DEA Is Making Now. It Also Named the People Who Would Spend 57 Years Stalling. The government’s closing brief in the marijuana rescheduling hearing was filed on August 17, 2026. It argues that cannabis has an accepted medical use, that the evidence has been sitting there for years, and that the people insisting the science isn’t ready yet are applying a standard the law does not require. Somebody made that argument first, on newsprint, for fifty cents, in the winter of 1969. The magazine was called The Marijuana Review. Volume one, number two, dated January through March 1969, twenty-four pages, published by an outfit called LeMar International out of Box 71, Norton Hall, at the State University of New York at Buffalo. LeMar was short for Legalize Marijuana. The editors listed on page 3 are Mike Aldrich and Ed Sanders. Under a heading reading “consultant gurus,” the first name is Allen Ginsberg.
Sep 10, 2026	CBD Helps Athletes Recover From Exercise But Does Not Boost Performance, Study Shows The cannabis component CBD “supports post-exercise recovery” for athletes “but does not directly enhance performance,” according to a new scientific review. Cannabidiol “demonstrates efficacy in modulating delayed-onset muscle soreness (DOMS) and lowering concentrations of muscle damage markers (creatine kinase and myoglobin), particularly within the 48-72 hour window following intensive exercise,” the paper, published in the International Medical Journal, found.
Sep 10, 2026	New Orleans’ French Quarter gets its first-ever marijuana dispensary. ‘I’m speechless.’ A brass band, feathered showgirls and brightly beaded Mardi Gras Indians brought the party to Bourbon Street on Wednesday morning, but it wasn’t for a wedding or a bachelor party — or anything to do with boozing on New Orleans’ most popular path for partygoers. The French Quarter’s first-ever cannabis dispensary opened its doors to customers in a 100-year-old building at 433 Bourbon St., offering three stories of edibles, vapes, cannabis flower as well as features like a third-floor gallery, theater experience and terpene smell bar.
Sep 10, 2026	Legalization Nation: Media misleading readers about cannabis safety – again Legalization Nation talks about cannabis from a ground-level perspective, addressing issues like the traditional market, patients’ rights, corporate advantage, and more, and compares state cannabis legalization policies to help make sense of a daunting landscape through a familiar medium.
Sep 9, 2026	New Review Challenges Evidence Behind Cannabis ‘Entourage Effect’ A comprehensive new review dives into the available research looking at the entourage effect for cannabis. This “entourage effect” is at the heart of the argument for why full-spectrum products are frequently presented as more medically effective than single-molecule pharmaceuticals like dronabinol, something cannabis consumers often echo through personal experience. First introduced in 1998 by Dr. Raphael Mechoulam and Dr. Shimon Ben-Shabat, the popular theory that whole-plant products offer superior medical outcomes and enhanced tolerability over isolated THC has become a foundational narrative shaping patient advocacy and commercial market strategy within the cannabis sector. However, the new review published in Current Neuropharmacology suggests that the scientific reality of these phytochemical interactions is far more complex, and often less conclusive, than popular consensus might sometimes imply.
Sep 9, 2026	CT cannabis company continues hostile takeover fight with Canadian rival Stamford-based cannabis giant Curaleaf Holdings has fired the latest salvo in its hostile takeover fight with Canadian company Aurora Cannabis. Curaleaf announced in August that it intended to acquire Aurora Cannabis for $4 per share, saying the proposal represented a 45% premium to Aurora’s 30-day average share price. The company said at the time it had initially approached Aurora privately in June and followed up in July after the Canadian company declined to engage.
Sep 9, 2026	Cannabis Policies In The Netherlands Have Plenty Of Room To Improve The Netherlands is well known around the world for its rich history with cannabis. One could easily argue that Amsterdam, the capital of the Netherlands, was the first international cannabis tourism destination. Cannabis consumers have traveled to Amsterdam to partake in local offerings for decades. In recent years, the Netherlands has ceded, to some degree, its title as the world’s top location for cannabis. Several governments around the world have modernized their laws and regulations to permit various cannabis activities, including cannabis commerce. Cannabis is now legal for adult use in Uruguay, Canada, Malta, Luxembourg, Germany, South Africa, and Czechia. Recreational cannabis is also legal at the state level in the U.S. in nearly half of the country’s states. Comparatively, while recreational cannabis activity has historically been largely tolerated in the Netherlands, it is not expressly legalized.
Sep 9, 2026	Can South Africa challenge Canada for global cannabis export dominance? In a challenge to licensed cannabis producers in Canada, long the global export leader, a growing share of cannabis exports is coming from companies in South Africa. Firms in South Africa enjoy lower production costs, but they’re also meeting European Union standards for pest control as well as EU-GMP requirements. With European markets increasingly interested in GMP-compliant product that’s also non-irradiated, South African cannabis producers are mounting a direct threat to Canadian LPs, operators told MJBizDaily. “South Africa is quickly becoming a serious exporter to Germany,” said Johan Slabber, the CEO of Nexus Pharma, which bills itself as South Africa’s first vertically integrated THC company.
Sep 9, 2026	Federal Court Lets Trump Move Ahead With Marijuana Rescheduling, Rejecting Pharma Company And Drug Testing Industry Request To Block It A federal appeals court has rejected a request from a drug testing industry association and a pharmaceutical company to block the Trump administration from moving forward with federal cannabis rescheduling while ongoing litigation challenging the reform is considered. “Petitioners have not satisfied the stringent requirements for a stay pending court review,” the U.S. Court of Appeals for the District of Columbia ruled on Wednesday.
Sep 9, 2026	State Department Warns Americans Against Traveling Internationally With Marijuana Or CBD Products The U.S. State Department is warning U.S. citizens against traveling internationally while carrying marijuana or CBD products. “U.S. citizens are subject to local laws,” the department’s Bureau of Consular Affairs said in a social media post on Tuesday. “Just because a cannabis, THC, or CBD product is legal in your home state does not mean you can take it abroad. This includes prescribed medical marijuana.”
Sep 9, 2026	Beer Buzz vs. Cannabis Buzz: What’s The Difference? There was a time when taking the edge off a long day at work was pretty straightforward. You had a beer. Today, the beverage aisle is getting considerably more complicated. THC-infused seltzers and other cannabis drinks are now part of the conversation, promising something beer has delivered for centuries: relaxation, a little mood alteration and maybe a more interesting evening. But a cannabis buzz isn’t just a beer buzz without the hops.
Sep 9, 2026	Study finds link between runner’s high and cannabis like molecules in long-distance runners A first-of-its-kind study, published in the journal BMC Medicine, has found that long-distance running can lead to an increase in the amount of THC-like molecules in the body. Researchers at the University of Duisburg-Essen found that levels of anandamide – an endocannabinoid sometimes called the “bliss molecule” – increased throughout a marathon and were still raised 45 minutes after runners had finished. The rise was much smaller when the same people walked the same route for the same amount of time.
Sep 9, 2026	Swiss Study: Regulating Cannabis ‘Promotes Safer Consumption’ Regional adult-use cannabis commerce pilot trials are currently operating in multiple jurisdictions in Switzerland, including Zurich, Basel, Lausanne, Geneva, and in the cantons of St Gallen and Basel-Country. The pilot trials allow adults to participate in limited recreational cannabis commerce (production, retail, and purchasing) so researchers, regulators, and lawmakers can gather information to better inform national laws and industry regulations.
Sep 9, 2026	Federal Prohibition Continues to Stifle Cannabis Banking Access in US and Beyond Federal Prohibition Continues to Stifle Cannabis Banking Access in US and Beyond A new report in the US looks at challenges and the regulatory landscape for financial institutions that serve state-licensed cannabis-related businesses, despite recent changes reclassifying state-regulated medical marijuana to Schedule 3. The new US Government Accountability Office (GAO) report, publicly released September 8, 2026, notes that despite more than a decade of state-level cannabis legalization in the United States, businesses operating in the sector continue to face significant financial hurdles due to federal prohibition.
Sep 8, 2026	India Was Forced to Outlaw Cannabis. I Think It’s Time to Undo That Mistake. In 1961, 13 years after its independence, India was forced by the U.S. to sign the Single Convention on Narcotic Drugs, which included cannabis, or in India, ganja. However, as far as cannabis was concerned, there were some problems.
Sep 8, 2026	Banks Hesitate to Serve Legal Cannabis Despite Federal Guidance Cannabis-related businesses experience bank account closures, high fees for bank accounts, and high interest rates for business loans, according to a recent Government Accountability Office (GAO) report, publicly released Sept. 8, 2026. The report exposes a fundamental contradiction in American financial policy: cannabis is legal in many states, yet federal law treats it as a controlled substance, creating a chilling effect on banks willing to serve the industry.
Sep 8, 2026	How El Niño Could Affect Cannabis If your cannabis plants seem unusually happy—or unusually stressed—this year, the weather may have something to do with it. As if the industry doesn’t have enough on their plate dealing with politicans, here is how El Niño could affect cannabis. 2026 is an El Niño year, and this year’s event is shaping up to be an unusually strong one. According to NOAA, El Niño is strengthening and has more than a 90% chance of becoming a very strong event during the fall and winter of 2026–27. Forecasters are also calling for an increased likelihood of unusual temperature and precipitation patterns across much of the United States.
Sep 8, 2026	Claims of Fentanyl Found in Cannabis Remain Unfounded Claims of fentanyl being found in cannabis in Canada periodically surface, although there have been no officially documented, laboratory-verified cases of cannabis being accidentally cross-contaminated with strong synthetic opioids like fentanyl in Canada’s cannabis market.
Sep 8, 2026	Why a cannabis business is betting on dogs to reach FDA approval Key points: Endovia Health Sciences is pursuing FDA approval for CannEpil, a pharmaceutical-grade drug containing CBD and THC isolates in a 20-to-1 ratio, to treat canine cancer-related pain. Veterinary pain management is expected to be a $3.8 billion market by 2030. Endovia is using the veterinary market as its first step toward pursuing human applications for CannEpil.

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76